Kevin L. Cornwell, the Chairman and CEO of Utah Medical Products Inc, has made a significant move by acquiring 1,000 shares of the company's common stock at a price of $66.75 per share. This transaction, filed on October 29, 2026, is a clear indication of Cornwell's confidence in the company's future prospects.

Utah Medical Products is a company that operates within the surgical and medical instruments industry. The firm is incorporated in Utah and has a fiscal year ending on December 31. Cornwell's recent acquisition of shares is a part of his ongoing commitment to the company, which is reflected in his substantial ownership stake.

The filing reveals that following this latest transaction, Cornwell now owns a total of 189,472 shares of Utah Medical Products. The filing states, "Transaction Code: P" indicating a purchase, and notes that the shares were acquired directly. Additionally, the filing includes a footnote clarifying that 6,000 shares are held by Cornwell's IRA, while 128,478 shares are held by the Cornwell Bypass Trust and 54,994 shares are held by the Cornwell Survivor's Trust.

This acquisition may have implications for other stakeholders, including investors and analysts who monitor insider trading as a potential indicator of a company's health and future performance. Insider purchases, like Cornwell's, can often be interpreted as a positive signal regarding the company's outlook.

Looking ahead, the filing does not specify what actions may follow this transaction. However, it underscores Cornwell's ongoing involvement and investment in Utah Medical Products, reinforcing the leadership's commitment to the company's growth and stability.